Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06441864 · ClinicalTrials.gov registry record · NA

Behavioral Treatment for Nightmares in REM Sleep Behavior Disorder

A NA study of REM Sleep Behavior Disorder and Nightmare, sponsored by University of Utah.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06441864: Recruiting NA study of REM Sleep Behavior Disorder and Nightmare, sponsored by University of Utah.

NCT06441864 is a NA study of REM Sleep Behavior Disorder and Nightmare that is actively recruiting participants, run by University of Utah. The registered enrollment target is 20 participants, below the 156-participant average among 11 other REM Sleep Behavior Disorder trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06441864, a NA study of REM Sleep Behavior Disorder and Nightmare, is actively recruiting participants, sponsored by University of Utah.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with Rapid Eye Movement (REM) Sleep Behavior Disorder (RBD). People with RBD will be enrolled in the study along with their family members (a partner or other family member residing in the same home). All participants will receive the treatment via videoconference and will complete 2 assessments. Participants with RBD will attend 7 sessions, and their family members will attend 2 of those sessions with them.

Primary Outcome

The DDNSI is a questionnaire which measures the severity of nightmares.

Conditions Studied

REM Sleep Behavior Disorder Nightmare Nightmare Disorder With Associated Other Sleep Disorder

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy for Nightmares

Study Locations (1)

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-07-15
Est. Completion 2026-12-01
Phase NA
University of Utah

818 total trials

What NCT06441864 shows while recruiting

NCT06441864 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 156-participant average among 11 other REM Sleep Behavior Disorder trials with a reported enrollment target (87% lower).

The record links to 3 conditions, with REM Sleep Behavior Disorder appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Therapy for Nightmares is the first listed.

NCT06441864 reports a single indexed study location in Utah.

Frequently Asked Questions

What is clinical trial NCT06441864 about?

NCT06441864 is a clinical study titled "Behavioral Treatment for Nightmares in REM Sleep Behavior Disorder". The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with Rapid Eye Movement (REM) Sleep Behavior Disorder (RBD). People with RBD will be enrolled in the study along with their family members (a partner or other family member res...

What is the current status of trial NCT06441864?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-07-15. Estimated completion is 2026-12-01.

What conditions does trial NCT06441864 study?

This clinical trial studies the following conditions: REM Sleep Behavior Disorder, Nightmare, Nightmare Disorder With Associated Other Sleep Disorder.

What interventions are being tested in trial NCT06441864?

The interventions under investigation include: Cognitive Behavioral Therapy for Nightmares (BEHAVIORAL).

Who is sponsoring clinical trial NCT06441864?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06441864 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for REM Sleep Behavior Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06441864's enrollment target sits among peer trials

20 8th of 11 higher than 4 of 11 other REM Sleep Behavior Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other REM Sleep Behavior Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06441864

Source: ClinicalTrials.gov NCT06441864, the US trial registry maintained by the National Library of Medicine. NCT06441864 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.